These results of this study are very different from those reported in the United States and Western Europe, where TP53 alterations are low and RB1 alterations are absent, suggesting that TP53 and RB1 alterations may be more common in Asian patients with ductal adenocarcinoma and may have more aggressive characteristics. This evidence concerns the gene TP53 and invasive ductal breast carcinoma.